1
|
Li X, Zeng H, Durairaj P, Wen W, Li T, Zhao Y, Liu Y, Liu X, Zhan L, Rao L, Yuan W, Guo T, Shen W, Cai H, Chen Z. Fully synthetic phosphorylated Tau181, Tau217, and Tau231 calibrators for Alzheimer's disease diagnosis. Front Aging Neurosci 2024; 15:1340706. [PMID: 38288278 PMCID: PMC10823022 DOI: 10.3389/fnagi.2023.1340706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2023] [Accepted: 12/27/2023] [Indexed: 01/31/2024] Open
Abstract
Background The calibrator in immunoassay plays an essential role in diagnosing Alzheimer's disease (AD). Presently, the most well-studied biomarkers for AD diagnosis are three phosphorylated Tau (p-Tau): p-Tau231, p-Tau217, and p-Tau181. Glycogen synthase-3beta (GSK3β)-phosphorated Tau-441 is the most commonly used calibrator for p-Tau immunoassays. However, the batch-to-batch inconsistency issue of the commonly used GSK3β-phosphorylated Tau-441 limits its clinical application. Methods We have successfully generated and characterized 61 Tau monoclonal antibodies (mAbs) with distinct epitopes by using the hybridoma technique and employed them as capture or detection antibodies for p-Tau immunoassays. Through chemical synthesis, we synthesized calibrators, which are three peptides including capture and detection antibody epitopes, for application in immunoassays that detect p-Tau231, p-Tau217, and p-Tau181. The novel calibrators were applied to Enzyme-linked immunosorbent assay (ELISA) and Single-molecule array (Simoa) platforms to validate their applicability and establish a range of p-Tau immunoassays. Results By employing the hybridoma technique, 49 mAbs recognizing Tau (1-22), nine mAbs targeting p-Tau231, one mAb targeting p-Tau217, and two mAbs targeting p-Tau181 were developed. Peptides, including recognition epitopes of capture and detection antibodies, were synthesized. These peptides were used as calibrators to develop 60 immunoassays on the ELISA platform, of which six highly sensitive immunoassays were selected and applied to the ultra-sensitive Simoa platform. Remarkably, the LODs were 2.5, 2.4, 31.1, 32.9, 46.9, and 52.1 pg/ml, respectively. Conclusion Three novel p-Tau calibrators were successfully generated and validated, which solved the batch-to-batch inconsistency issue of GSK3β-phosphorylated Tau-441. The novel calibrators exhibit the potential to promote the standardization of clinical AD diagnostic calibrators. Furthermore, we established a series of highly sensitive and specific immunoassays on the Simoa platform based on novel calibrators, which moved a steady step forward in p-Tau immunoassay application for AD diagnosis.
Collapse
Affiliation(s)
- Xinyu Li
- School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China
| | - Huimei Zeng
- Center for Translational Research, Shenzhen Bay Laboratory, Shenzhen, China
| | | | - Weihuan Wen
- Center for Translational Research, Shenzhen Bay Laboratory, Shenzhen, China
| | - Tianpeng Li
- Center for Translational Research, Shenzhen Bay Laboratory, Shenzhen, China
| | - Yanru Zhao
- Center for Translational Research, Shenzhen Bay Laboratory, Shenzhen, China
| | - Yang Liu
- Center for Translational Research, Shenzhen Bay Laboratory, Shenzhen, China
| | - Xue Liu
- Center for Translational Research, Shenzhen Bay Laboratory, Shenzhen, China
| | - Lingpeng Zhan
- Institute for Cell Analysis, Shenzhen Bay Laboratory, Shenzhen, China
| | - Lang Rao
- Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, China
| | - Wen Yuan
- Institute of Neurological Diseases, Shenzhen Bay Laboratory, Shenzhen, China
| | - Tengfei Guo
- Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China
| | - Weijun Shen
- Center for Translational Research, Shenzhen Bay Laboratory, Shenzhen, China
| | - Hui Cai
- School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China
| | - Zhicheng Chen
- Center for Translational Research, Shenzhen Bay Laboratory, Shenzhen, China
| |
Collapse
|
2
|
Hauser S, Lazarevic V, Tournoud M, Ruppé E, Santiago Allexant E, Guigon G, Schicklin S, Lanet V, Girard M, Mirande C, Gervasi G, Schrenzel J. A metagenomics method for the quantitative detection of bacterial pathogens causing hospital-associated and ventilator-associated pneumonia. Microbiol Spectr 2023; 11:e0129423. [PMID: 37889000 PMCID: PMC10715005 DOI: 10.1128/spectrum.01294-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 09/29/2023] [Indexed: 10/28/2023] Open
Abstract
IMPORTANCE The management of ventilator-associated pneumonia and hospital-acquired pneumonia requires rapid and accurate quantitative detection of the infecting pathogen. To this end, we propose a metagenomic sequencing assay that includes the use of an internal sample processing control for the quantitative detection of 20 relevant bacterial species from bronchoalveolar lavage samples.
Collapse
Affiliation(s)
| | - V. Lazarevic
- Genomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
| | | | - E. Ruppé
- Genomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
| | | | | | | | - V. Lanet
- bioMérieux, Marcy-l'Étoile, France
| | - M. Girard
- Genomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
| | - C. Mirande
- bioMérieux, La Balme-les-Grottes, France
| | | | - J. Schrenzel
- Genomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
| |
Collapse
|
3
|
Rojansky R, Sompuram SR, Gomulia E, Natkunam Y, Troxell ML, Fernandez-Pol S. Digital Image Analysis and Quantitative Bead Standards in Root Cause Analysis of Immunohistochemical Staining Variability: A Real-world Example. Appl Immunohistochem Mol Morphol 2022; 30:477-485. [PMID: 35876743 PMCID: PMC9345521 DOI: 10.1097/pai.0000000000001045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Accepted: 05/04/2022] [Indexed: 11/25/2022]
Abstract
Assessment of automated immunohistochemical staining platform performance is largely limited to the visual evaluation of individual slides by trained personnel. Quantitative assessment of stain intensity is not typically performed. Here we describe our experience with 2 quantitative strategies that were instrumental in root cause investigations performed to identify the sources of suboptimal staining quality (decreased stain intensity and increased variability). In addition, these tools were utilized as adjuncts in validation of a new immunohistochemical staining instrument. The novel methods utilized in the investigation include quantitative assessment of whole slide images (WSI) and commercially available quantitative calibrators. Over the course of ~13 months, these methods helped to identify and verify correction of 2 sources of suboptimal staining. One root cause of suboptimal staining was insufficient/variable power delivery from our building's electrical circuit. This led us to use uninterruptible power managers for all automated immunostainer instruments, which restored expected stain intensity and consistency. Later, we encountered one instrument that, despite passing all vendor quality control checks and not showing error alerts was suspected of yielding suboptimal stain quality. WSI analysis and quantitative calibrators provided a clear evidence that proved critical in confirming the pathologists' visual impressions. This led to the replacement of the instrument, which was then validated using a combination of standard validation metrics supplemented by WSI analysis and quantitative calibrators. These root cause analyses document 2 variables that are critical in producing optimal immunohistochemical stain results and also provide real-world examples of how the application of quantitative tools to measure automated immunohistochemical stain output can provide a greater objectivity when assessing immunohistochemical stain quality.
Collapse
Affiliation(s)
- Rebecca Rojansky
- Department of Pathology, Stanford University School of Medicine, Stanford, CA
| | | | - Ellen Gomulia
- Department of Pathology, Stanford University School of Medicine, Stanford, CA
| | - Yasodha Natkunam
- Department of Pathology, Stanford University School of Medicine, Stanford, CA
| | - Megan L. Troxell
- Department of Pathology, Stanford University School of Medicine, Stanford, CA
| | | |
Collapse
|
4
|
Das S, Dewit N, Jacobs D, Pijnenburg YAL, In 't Veld SGJG, Coppens S, Quaglia M, Hirtz C, Teunissen CE, Vanmechelen E. A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration. Int J Mol Sci 2022; 23. [PMID: 35806226 DOI: 10.3390/ijms23137221] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Revised: 06/22/2022] [Accepted: 06/27/2022] [Indexed: 01/27/2023] Open
Abstract
Neurofilament light chain (Nf-L) is a well-known biomarker for axonal damage; however, the corresponding circulating Nf-L analyte in cerebrospinal fluid (CSF) is poorly characterized. We therefore isolated new monoclonal antibodies against synthetic peptides, and these monoclonals were characterized for their specificity on brain-specific intermediate filament proteins. Two highly specific antibodies, ADx206 and ADx209, were analytically validated for CSF applications according to well-established criteria. Interestingly, using three different sources of purified Nf-L proteins, a significant impact on interpolated concentrations was observed. With a lower limit of analytical sensitivity of 100 pg/mL using bovine Nf-L as the calibrator, we were able to quantify the Nf-L analyte in each sample, and these Nf-L concentrations were highly correlated to the Uman diagnostics assay (Spearman rho = 0.97, p < 0.001). In the clinical diagnostic groups, the new Nf-L ELISA could discriminate patients with Alzheimer’s disease (AD, n = 20) from those with frontotemporal lobe dementia (FTD, n = 20) and control samples with subjective cognitive decline (SCD, n = 20). Henceforth, this novel Nf-L ELISA with well-defined specificity and epitopes can be used to enhance our understanding of harmonizing the use of Nf-L as a clinically relevant marker for neurodegeneration in CSF.
Collapse
|
5
|
Huang X, Ahola H, Daly M, Nitride C, Mills ENC, Sontag-Strohm T. Quantification of Barley Contaminants in Gluten-Free Oats by Four Gluten ELISA Kits. J Agric Food Chem 2022; 70:2366-2373. [PMID: 35156817 PMCID: PMC8880376 DOI: 10.1021/acs.jafc.1c07715] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Abstract
Pure oats are generally accepted to be safe for most celiac patients, and consumption of oats provides advantageous dietary fibers. However, oats can be contaminated by gluten proteins from wheat, barley, and/or rye. The analytical challenge lies in the reliability of the quantification method and how to maintain the contamination level under a gluten-free food threshold of 20 mg/kg. In this study, we investigated barley-spiked oat flour samples at four levels using four gluten ELISA kits. The largest recovery variance was with the R5 kit that gave 5-6 times overestimation; the G12 kit cross-reacted with oat proteins and gave 4-5 times overestimation at all spiked levels. The Total Gluten and Morinaga kits gave satisfactory recoveries. Total barley hordeins were isolated and characterized to be used as a common calibrator in all four kits aiming at harmonizing the results and to test the kits' performance. Immunoblotting of total hordein isolate revealed that Total Gluten and Morinaga antibodies provided an overall detection, while R5 and G12 antibodies recognized specific hordein groups leading to a larger difference when wheat and barley were used as the calibrant. Calibration with total hordein isolate corrected the overestimation problem and decreased the variability between the four gluten kits.
Collapse
Affiliation(s)
- Xin Huang
- Department
of Food and Nutrition, Faculty of Agriculture and Forestry, University of Helsinki, FI-00014 Helsinki, Finland
| | - Hanna Ahola
- Department
of Food and Nutrition, Faculty of Agriculture and Forestry, University of Helsinki, FI-00014 Helsinki, Finland
| | - Matthew Daly
- Manchester
Institute of Biotechnology, Division of Infection, Immunity and Respiratory
Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M17DN, U.K.
| | - Chiara Nitride
- Manchester
Institute of Biotechnology, Division of Infection, Immunity and Respiratory
Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M17DN, U.K.
- Department
of Agricultural Sciences, University of
Naples Federico II, 80055 Portici, Italy
| | - EN Clare Mills
- Manchester
Institute of Biotechnology, Division of Infection, Immunity and Respiratory
Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M17DN, U.K.
| | - Tuula Sontag-Strohm
- Department
of Food and Nutrition, Faculty of Agriculture and Forestry, University of Helsinki, FI-00014 Helsinki, Finland
| |
Collapse
|
6
|
Mingotti A, Costa F, Cavaliere D, Peretto L, Tinarelli R. On the Importance of Characterizing Virtual PMUs for Hardware-in-the-Loop and Digital Twin Applications. Sensors (Basel) 2021; 21:6133. [PMID: 34577340 DOI: 10.3390/s21186133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/12/2021] [Revised: 09/08/2021] [Accepted: 09/10/2021] [Indexed: 11/17/2022]
Abstract
In recent years, the introduction of real-time simulators (RTS) has changed the way of researching the power network. In particular, researchers and system operators (SOs) are now capable of simulating the complete network and of making it interact with the real world thanks to the hardware-in-the-loop (HIL) and digital twin (DT) concepts. Such tools create infinite scenarios in which the network can be tested and virtually monitored to, for example, predict and avoid faults or energy shortages. Furthermore, the real-time monitoring of the network allows estimating the status of the electrical assets and consequently undertake their predictive maintenance. The success of the HIL and DT application relies on the fact that the simulated network elements (cables, generation, accessories, converters, etc.) are correctly modeled and characterized. This is particularly true if the RTS acquisition capabilities are used to enable the HIL and the DT. To this purpose, this work aims at emphasizing the role of a preliminary characterization of the virtual elements inside the RTS system, experimentally verifying how the overall performance is significantly affected by them. To this purpose, a virtual phasor measurement unit (PMU) is tested and characterized to understand its uncertainty contribution. To achieve that, firstly, the characterization of a virtual PMU calibrator is described. Afterward, the virtual PMU calibration is performed, and the results clearly highlight its key role in the overall uncertainty. It is then possible to conclude that the characterization of the virtual elements, or models, inside RTS systems (omitted most of the time) is fundamental to avoid wrong results. The same concepts can be extended to all those fields that exploit HIL and DT capabilities.
Collapse
|
7
|
Hayden RT, Tang L, Su Y, Cook L, Gu Z, Jerome KR, Boonyaratanakornkit J, Sam S, Pounds S, Caliendo AM. Impact of Fragmentation on Commutability of Epstein-Barr Virus and Cytomegalovirus Quantitative Standards. J Clin Microbiol 2019; 58:e00888-19. [PMID: 31619529 DOI: 10.1128/JCM.00888-19] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2019] [Accepted: 10/07/2019] [Indexed: 12/23/2022] Open
Abstract
Despite the adaptation of international standards, quantitative viral load testing of transplant-associated viruses continues to be limited by interlaboratory disagreement. Studies have suggested that this disagreement and the poor commutability of standards may, in some cases, be linked to amplicon size and the fragmentation of circulating viral DNA. We evaluated target fragmentation as a cause of noncommutability and pretest fragmentation of quantitative standards as a potential means of increasing commutability and interassay agreement. Forty-two cytomegalovirus (CMV)-positive and 41 Epstein-Barr virus (EBV)-positive plasma samples, together with two different quantitative standards for each virus, were tested as unknowns using 10 different quantitative PCR assays at 5 different laboratories. Standards were tested both intact and after intentional fragmentation by ultrasonication. Quantitative agreement between methods was assessed, together with commutability, using multiple statistical approaches. Most assays yielded results within 0.5 log10 IU/ml of the mean for CMV, while for EBV a greater variability of up to 1.5 log10 IU/ml of the mean was shown. Commutability showed marked improvement following fragmentation of both CMV standards but not after fragmentation of the EBV standards. These findings confirm the impact of amplicon size and target fragmentation on commutability for CMV and suggest that for some (but not all) viruses, interlaboratory harmonization can be improved through the use of fragmented quantitative standards.
Collapse
|
8
|
Punwani D, Gonzalez-Espinosa D, Comeau AM, Dutra A, Pak E, Puck J. Cellular calibrators to quantitate T-cell receptor excision circles (TRECs) in clinical samples. Mol Genet Metab 2012; 107:586-91. [PMID: 23062576 PMCID: PMC3483425 DOI: 10.1016/j.ymgme.2012.09.018] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2012] [Revised: 09/15/2012] [Accepted: 09/15/2012] [Indexed: 11/17/2022]
Abstract
T-cell receptor excision circles (TRECs) are circular DNA molecules formed during rearrangement of the T-cell receptor (TCR) genes during lymphocyte development. Copy number of the junctional portion of the δRec-ψJα TREC, assessed by quantitative PCR (qPCR) using DNA from dried blood spots (DBS), is a biomarker for newly formed T cells and absent or low numbers of TRECs indicate SCID (severe combined immunodeficiency) or T lymphocytopenia. No quantitation standard for TRECs exists. To permit comparison of TREC qPCR results with a reliable method for counting TRECs across different laboratories, we sought to construct a stable cell line containing a normal human chromosomal constitution and a single copy of the TREC junction sequence. A human EBV (Epstein Barr virus)-transformed B-cell line was transduced with a lentivirus encoding mCherry fluorescence, puromycin resistance and the δRec-ψJα TREC sequence. A TREC-EBV cell line, with each cell carrying a single lentiviral insertion was established, expanded and shown to have one TREC copy per diploid genome. Graded numbers of TREC-EBV cells added to aliquots of T lymphocyte depleted blood showed TREC copy number proportional to TREC-EBV cell number. TREC-EBV cells, therefore, constitute a reproducible cellular calibrator for TREC assays, useful for both population-based screening for severe combined immunodeficiency and evaluation of naïve T-cell production in clinical settings.
Collapse
Affiliation(s)
- Divya Punwani
- Dept. of Pediatrics, University of California San Francisco, San Francisco, CA 91413; USA
| | | | - Anne Marie Comeau
- New England Newborn Screening Program, Dept. of Pediatrics, University of Massachusetts Medical School, Worcester, MA 01610; USA
| | - Amalia Dutra
- National Human Genome Research Institute, NIH, Bethesda, MD 20892; USA
| | - Evgenia Pak
- National Human Genome Research Institute, NIH, Bethesda, MD 20892; USA
| | - Jennifer Puck
- Dept. of Pediatrics, University of California San Francisco, San Francisco, CA 91413; USA
- Corresponding author: Jennifer M. Puck, MD, UCSF Department of Pediatrics, Box 0519, 513 Parnassus Avenue, HSE 301A, San Francisco, CA 94143-0519,
| |
Collapse
|
9
|
Tsao K, Liu G, Chang P, Lin C, Wu T, Sun C, Wu J. Characterization of serum and urinary chromogranin A by size exclusion chromatography: impact on calibrator selection and urinary assay. J Clin Lab Anal 2001; 15:193-8. [PMID: 11436202 PMCID: PMC6807791 DOI: 10.1002/jcla.1027] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Serum chromogranin A (CgA) is a useful marker for neuroendocrine tumors and is detectable in carcinomas at advanced stages. Elevated serum CgA is also an indicator of poor prognosis in prostate cancer and is useful for predicting the failure of hormonal therapy for prostate cancer patients. We found that CgA molecules with three different sizes could be detected in normal human serum. However, only the largest CgA molecule appears in patients with liver disease. Serum taken from cancer patients is composed predominantly of the middle-sized molecule, whereas the smallest CgA molecule was elevated in serum drawn from renal patients. Moreover, only the smallest CgA molecule was found in urine. We believe that the largest CgA molecule is metabolized by the liver, whereas the smallest CgA molecule is removed from the blood circulation via the kidney. Because the medium-sized CgA is the dominant molecule in both the cell medium of the tumor cell line SK-N-AS and sera from patients with malignant diseases, CgA from the cell medium was selected as the calibrator for the CgA ELISA assay. Our findings also suggest that it would not be possible to measure the urinary CgA to reflect the serum CgA concentration in order to detect pheochromocytoma among patients with hypertension.
Collapse
Affiliation(s)
- K.‐C. Tsao
- Department of Pathology, Chang Gung Memorial Hospital, Taipei, Taiwan
| | - G.H. Liu
- Department of Pathology and ARUP, University of Utah Health Sciences Center, Salt Lake City, Utah
| | - P.‐Y. Chang
- Department of Pathology, Chang Gung Memorial Hospital, Taipei, Taiwan
| | - C.‐N. Lin
- Department of Pathology, Chang Gung Memorial Hospital, Taipei, Taiwan
| | - T.‐L. Wu
- Department of Pathology, Chang Gung Memorial Hospital, Taipei, Taiwan
| | - C.‐F. Sun
- Department of Pathology, Chang Gung Memorial Hospital, Taipei, Taiwan
| | - J.T. Wu
- Department of Pathology and ARUP, University of Utah Health Sciences Center, Salt Lake City, Utah
| |
Collapse
|